Cidara Therapeutics
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases. The company utilizes its Cloudbreak platform to create single-molecule cocktails that combine small molecules and peptides with human antibody fragments. These drug-Fc conjugate immunotherapies are designed to target specific disease mechanisms while simultaneously activating the immune system. Cidara focuses on applications in infectious diseases, such as influenza, as well as in immuno-oncology. Its approach integrates molecular targeting with immune engagement to address challenging medical conditions. The company continues to advance its pipeline of therapies through research and development initiatives.
Domain
cidara.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$339.0M
Founded
2011
Tech Stack (13 technologies)
Frequently Asked Questions
What technologies does Cidara Therapeutics use?+
Cidara Therapeutics uses 13 technologies including Google Analytics, Google Tag Manager, OneTrust.
What industry is Cidara Therapeutics in?+
Cidara Therapeutics operates in the Biotechnology industry.
Where is Cidara Therapeutics based?+
Cidara Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: July 2026